Last 12 months
Inside the activity.
15 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 4 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 4 | 0 |
| Oct 2026 | 3 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2023 Filed Mar 23, 2023 01:30 UTC |
Walker Karin LChief Accounting Officer
|
SaleOrdinary Shares, par value $0.01 per share | 1,097 | $48.47 | $53,166.43 |
DisclosureSEC source: 0001140361-23-013190 · form4.xml · nonDerivative · entry 3 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $48.33 to $48.73, inclusive. Read SEC document |
| March 20, 2023 Filed Mar 23, 2023 01:30 UTC |
Walker Karin LChief Accounting Officer
|
SaleOrdinary Shares, par value $0.01 per share | 3,903 | $47.51 | $185,443.24 |
DisclosureSEC source: 0001140361-23-013190 · form4.xml · nonDerivative · entry 2 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,097 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $47.305 to $48.22, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4. Read SEC document |
| March 20, 2023 Filed Mar 23, 2023 01:30 UTC |
Walker Karin LChief Accounting Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $15.04 | $75,200.00 |
DisclosureSEC source: 0001140361-23-013190 · form4.xml · nonDerivative · entry 1 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:30 UTC |
Garren HidekiChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $24.90 | $0.00 |
DisclosureSEC source: 0001567619-23-005288 · doc1.xml · derivative · entry 4 Garren Hideki · CIK 0001854126 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Ordinary Shares · 12,000 shares Expires 2031-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:30 UTC |
Garren HidekiChief Medical Officer
|
SaleOrdinary Shares, par value $0.01 per share | 6,000 | $48.66 | $291,969.60 |
DisclosureSEC source: 0001567619-23-005288 · doc1.xml · nonDerivative · entry 3 Garren Hideki · CIK 0001854126 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $48.44 to $49.06, inclusive. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:30 UTC |
Garren HidekiChief Medical Officer
|
SaleOrdinary Shares, par value $0.01 per share | 6,000 | $48.16 | $288,966.00 |
DisclosureSEC source: 0001567619-23-005288 · doc1.xml · nonDerivative · entry 2 Garren Hideki · CIK 0001854126 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $47.43 to $48.42, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:30 UTC |
Garren HidekiChief Medical Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 12,000 | $24.90 | $298,800.00 |
DisclosureSEC source: 0001567619-23-005288 · doc1.xml · nonDerivative · entry 1 Garren Hideki · CIK 0001854126 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Nguyen TranChief Strategy Officer and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.73 | $0.00 |
DisclosureSEC source: 0001567619-23-005291 · doc1.xml · derivative · entry 4 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires 2023-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was granted on April 1, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately one month and be forfeited to the extent it is not exercised on or prior to March 31, 2023. F5 · balance_after: The Reporting Person holds options that give him the right to acquire an aggregate of 901,837 shares at exercise prices ranging from $6.73 to $52.97, of which 721,837 are currently exercisable, and 180,000 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. Certain of these options are subject to the Court Order. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Nguyen TranChief Strategy Officer and CFO
|
SaleOrdinary Shares, par value $0.01 per share | 5,198 | $48.68 | $253,028.76 |
DisclosureSEC source: 0001567619-23-005291 · doc1.xml · nonDerivative · entry 3 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and order regarding the separation of assets ("Court Order") in accordance with a divorce settlement agreement. F3 · price: The transaction was executed in multiple trades in prices ranging from $48.43 to $49.03, inclusive. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Nguyen TranChief Strategy Officer and CFO
|
SaleOrdinary Shares, par value $0.01 per share | 4,802 | $48.16 | $231,285.45 |
DisclosureSEC source: 0001567619-23-005291 · doc1.xml · nonDerivative · entry 2 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,398 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and order regarding the separation of assets ("Court Order") in accordance with a divorce settlement agreement. F2 · price: The transaction was executed in multiple trades in prices ranging from $47.43 to $48.405, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Nguyen TranChief Strategy Officer and CFO
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 10,000 | $6.73 | $67,300.00 |
DisclosureSEC source: 0001567619-23-005291 · doc1.xml · nonDerivative · entry 1 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:32 UTC |
Walker Karin LChief Accounting Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $15.04 | $0.00 |
DisclosureSEC source: 0001567619-23-005293 · doc1.xml · derivative · entry 4 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,481 Underlying: Ordinary Shares · 20,000 shares Expires 2028-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on June 21, 2019, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:32 UTC |
Walker Karin LChief Accounting Officer
|
SaleOrdinary Shares, par value $0.01 per share | 10,569 | $48.66 | $514,331.93 |
DisclosureSEC source: 0001567619-23-005293 · doc1.xml · nonDerivative · entry 3 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $48.43 to $49.06, inclusive. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:32 UTC |
Walker Karin LChief Accounting Officer
|
SaleOrdinary Shares, par value $0.01 per share | 9,431 | $48.14 | $454,014.00 |
DisclosureSEC source: 0001567619-23-005293 · doc1.xml · nonDerivative · entry 2 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,569 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $47.43 to $48.42, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:32 UTC |
Walker Karin LChief Accounting Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 20,000 | $15.04 | $300,800.00 |
DisclosureSEC source: 0001567619-23-005293 · doc1.xml · nonDerivative · entry 1 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Malecek Michael JChief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.27 | $0.00 |
DisclosureSEC source: 0001567619-23-005290 · doc1.xml · derivative · entry 4 Malecek Michael J · CIK 0001779336 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Ordinary Shares · 15,000 shares Expires 2029-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on July 1, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Malecek Michael JChief Legal Officer
|
SaleOrdinary Shares, par value $0.01 per share | 8,564 | $48.67 | $416,799.60 |
DisclosureSEC source: 0001567619-23-005290 · doc1.xml · nonDerivative · entry 3 Malecek Michael J · CIK 0001779336 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $48.435 to $49.13, inclusive. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Malecek Michael JChief Legal Officer
|
SaleOrdinary Shares, par value $0.01 per share | 6,436 | $48.13 | $309,792.35 |
DisclosureSEC source: 0001567619-23-005290 · doc1.xml · nonDerivative · entry 2 Malecek Michael J · CIK 0001779336 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,564 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $47.43 to $48.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4. Read SEC document |
| March 15, 2023 Filed Mar 18, 2023 01:31 UTC |
Malecek Michael JChief Legal Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 15,000 | $10.27 | $154,050.00 |
DisclosureSEC source: 0001567619-23-005290 · doc1.xml · nonDerivative · entry 1 Malecek Michael J · CIK 0001779336 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:30 UTC |
Garren HidekiChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010182 · form4.xml · derivative · entry 1 Garren Hideki · CIK 0001854126 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:31 UTC |
Smith Brandon S.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010185 · form4.xml · derivative · entry 1 Smith Brandon S. · CIK 0001805226 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:30 UTC |
Zago Wagner M.Chief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010184 · form4.xml · derivative · entry 1 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:31 UTC |
Karp Carol D.Chief Regulatory Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010186 · form4.xml · derivative · entry 1 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010183 · form4.xml · derivative · entry 1 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. F2 · balance_after: The Reporting Person holds options that give him the right to acquire an aggregate of 911,837 shares at exercise prices ranging from $6.73 to $52.97, of which 731,837 are currently exercisable, and 180,000 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. Certain of these options are subject to an order regarding the separation of assets in accordance with a divorce settlement agreement. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:31 UTC |
Malecek Michael JChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010187 · form4.xml · derivative · entry 1 Malecek Michael J · CIK 0001779336 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:30 UTC |
Kinney Gene G.President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 155,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010181 · form4.xml · derivative · entry 1 Kinney Gene G. · CIK 0001564380 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,000 Underlying: Ordinary Shares · 155,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. F2 · balance_after: The Reporting Person holds options that give him the right to acquire an aggregate of 2,159,700 shares at exercise prices ranging from $12.15 to $52.97, of which 1,642,200 are currently exercisable, and 517,500 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:30 UTC |
Walker Karin LChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $52.97 | $0.00 |
DisclosureSEC source: 0001140361-23-010180 · form4.xml · derivative · entry 1 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Ordinary Shares · 38,000 shares Expires 2033-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.73 | $0.00 |
DisclosureSEC source: 0001567619-23-003363 · doc1.xml · derivative · entry 4 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2023-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was granted on April 1, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to March 31, 2023. F5 · balance_after: The Reporting Person holds options that give him the right to acquire an aggregate of 863,837 shares at exercise prices ranging from $6.73 to $32.45, of which 704,669 are currently exercisable, and 159,168 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. Certain of these options are subject to the Court Order. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
SaleOrdinary Shares, par value $0.01 per share | 664 | $53.87 | $35,770.68 |
DisclosureSEC source: 0001567619-23-003363 · doc1.xml · nonDerivative · entry 3 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and order regarding the separation of assets ("Court Order") in accordance with a divorce settlement agreement. F3 · price: The transaction was executed in multiple trades in prices ranging from $53.87 to $53.88, inclusive. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
SaleOrdinary Shares, par value $0.01 per share | 9,336 | $53.30 | $497,626.54 |
DisclosureSEC source: 0001567619-23-003363 · doc1.xml · nonDerivative · entry 2 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and order regarding the separation of assets ("Court Order") in accordance with a divorce settlement agreement. F2 · price: The transaction was executed in multiple trades in prices ranging from $52.835 to $53.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 10,000 | $6.73 | $67,300.00 |
DisclosureSEC source: 0001567619-23-003363 · doc1.xml · nonDerivative · entry 1 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.73 | $0.00 |
DisclosureSEC source: 0001567619-23-001097 · doc1.xml · derivative · entry 5 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 10,000 shares Expires 2023-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was granted on April 1, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to March 31, 2023. F6 · balance_after: The Reporting Person holds options that give him the right to acquire an aggregate of 873,837 shares at exercise prices ranging from $6.73 to $32.45, of which 708,753 are currently exercisable, and 165,084 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. Certain of these options are subject to the Court Order. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
SaleOrdinary Shares, par value $0.01 per share | 638 | $56.97 | $36,347.43 |
DisclosureSEC source: 0001567619-23-001097 · doc1.xml · nonDerivative · entry 4 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and proposed order regarding the separation of assets ("Court Order") in anticipation of a potential divorce settlement agreement. F4 · price: The transaction was executed in multiple trades in prices ranging from $56.815 to $57.355, inclusive. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
SaleOrdinary Shares, par value $0.01 per share | 2,085 | $56.32 | $117,435.96 |
DisclosureSEC source: 0001567619-23-001097 · doc1.xml · nonDerivative · entry 3 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,838 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and proposed order regarding the separation of assets ("Court Order") in anticipation of a potential divorce settlement agreement. F3 · price: The transaction was executed in multiple trades in prices ranging from $55.78 to $56.755, inclusive. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
SaleOrdinary Shares, par value $0.01 per share | 7,277 | $55.18 | $401,523.03 |
DisclosureSEC source: 0001567619-23-001097 · doc1.xml · nonDerivative · entry 2 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,923 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and proposed order regarding the separation of assets ("Court Order") in anticipation of a potential divorce settlement agreement. F2 · price: The transaction was executed in multiple trades in prices ranging from $54.77 to $55.755, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 4 of this Form 4. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 02:30 UTC |
Nguyen TranChief Strategy Officer and CFO
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 10,000 | $6.73 | $67,300.00 |
DisclosureSEC source: 0001567619-23-001097 · doc1.xml · nonDerivative · entry 1 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2023 Filed Jan 13, 2023 02:31 UTC |
Cooke ShaneDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-23-000905 · doc1.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023. F3 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023. Read SEC document |
| January 10, 2023 Filed Jan 13, 2023 02:31 UTC |
Cooke ShaneDirector
|
SaleOrdinary Shares, par value $0.01 per share | 5,000 | $52.92 | $264,608.00 |
DisclosureSEC source: 0001567619-23-000905 · doc1.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $52.28 to $53.175, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4. Read SEC document |
| January 10, 2023 Filed Jan 13, 2023 02:31 UTC |
Cooke ShaneDirector
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001567619-23-000905 · doc1.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 02:38 UTC |
COLLIER RICHARD TDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-23-000573 · doc1.xml · derivative · entry 3 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023. F3 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 02:38 UTC |
COLLIER RICHARD TDirector
|
SaleOrdinary Shares, par value $0.01 per share | 5,000 | $52.67 | $263,350.00 |
DisclosureSEC source: 0001567619-23-000573 · doc1.xml · nonDerivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $52.215 to $53.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 02:38 UTC |
COLLIER RICHARD TDirector
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 5,000 | $6.41 | $32,050.00 |
DisclosureSEC source: 0001567619-23-000573 · doc1.xml · nonDerivative · entry 1 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,834 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · derivative · entry 9 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,834 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
SaleOrdinary Shares, par value $0.01 per share | 69 | $60.85 | $4,198.42 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · nonDerivative · entry 8 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The transaction was executed in multiple trades in prices ranging from $60.77 to $61.00, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
SaleOrdinary Shares, par value $0.01 per share | 10 | $59.46 | $594.60 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · nonDerivative · entry 7 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
SaleOrdinary Shares, par value $0.01 per share | 1,523 | $58.67 | $89,353.19 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · nonDerivative · entry 6 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The transaction was executed in multiple trades in prices ranging from $58.195 to $58.92, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
SaleOrdinary Shares, par value $0.01 per share | 1,303 | $56.98 | $74,243.51 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · nonDerivative · entry 5 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,845 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The transaction was executed in multiple trades in prices ranging from $56.76 to $57.31, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
SaleOrdinary Shares, par value $0.01 per share | 6,621 | $56.33 | $372,970.20 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · nonDerivative · entry 4 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,148 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $55.76 to $56.755, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
SaleOrdinary Shares, par value $0.01 per share | 2,897 | $55.35 | $160,340.84 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · nonDerivative · entry 3 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,769 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $54.75 to $55.74, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:42 UTC |
Ekman LarsDirector · Chair of the Board
|
SaleOrdinary Shares, par value $0.01 per share | 3,411 | $54.15 | $184,706.67 |
DisclosureSEC source: 0001567619-23-000574 · doc1.xml · nonDerivative · entry 2 Ekman Lars · CIK 0001376117 · Director · Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,666 F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $53.74 to $54.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 7 of this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.